Divi's Laboratories (BOM:532488) Change In Payables And Accrued Expense : ₹0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Change In Payables And Accrued Expense?

Divi's Laboratories's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was ₹0 Mil. It means Divi's Laboratories's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Divi's Laboratories's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0 Mil. It means Divi's Laboratories's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Divi's Laboratories Change In Payables And Accrued Expense Historical Data

The historical data trend for Divi's Laboratories's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Change In Payables And Accrued Expense Chart

Divi's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Divi's Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Divi's Laboratories Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Divi's Laboratories Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

DIVISLAB:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines